Original Research
Published on 15 Jan 2026
Pyridoxamine reduces inflammatory and microcirculatory abnormalities in metabolic dysfunction-associated steatohepatitis and modulates key factors in the hepatic AGE/ALE signaling pathway
in Metabolic Physiology
- 1,066 views





